These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Tu ST; Chang SJ; Chen JF; Tien KJ; Hsiao JY; Chen HC; Hsieh MC Arch Intern Med; 2010 Jan; 170(2):155-61. PubMed ID: 20101010 [TBL] [Abstract][Full Text] [Related]
43. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria. Dullaart RP; Dikkeschei LD; Doorenbos H Diabetologia; 1989 Sep; 32(9):685-9. PubMed ID: 2507381 [TBL] [Abstract][Full Text] [Related]
44. Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study. Bakris GL; Smith AC; Richardson DJ; Hung E; Preston R; Goldberg R; Epstein M J Hum Hypertens; 2002 Mar; 16(3):185-91. PubMed ID: 11896508 [TBL] [Abstract][Full Text] [Related]
45. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582 [TBL] [Abstract][Full Text] [Related]
46. Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young. Jialal I; Deppe W; Joubert SM S Afr Med J; 1985 Jun; 67(25):1001-4. PubMed ID: 4012462 [TBL] [Abstract][Full Text] [Related]
47. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women. al-Muhtaseb N; al-Yuosuf AR; Bajaj JS Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693 [TBL] [Abstract][Full Text] [Related]
48. Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients. Durlach V; Gillery P; Bertin E; Taupin JM; Grulet H; Gross A; Leutenegger M Diabetes Metab; 1996 Oct; 22(5):319-23. PubMed ID: 8896993 [TBL] [Abstract][Full Text] [Related]
49. Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM. Watts GF; ap Gwilym RM; Mazurkiewicz J; Coltart J Diabetes Care; 1995 Feb; 18(2):234-6. PubMed ID: 7729303 [TBL] [Abstract][Full Text] [Related]
50. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Niskanen LK; Penttilã I; Parviainen M; Uusitupa MI Diabetes Care; 1996 May; 19(5):486-93. PubMed ID: 8732714 [TBL] [Abstract][Full Text] [Related]
51. Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels. Wolffenbuttel BH; Leurs PB; Sels JP; Rondas-Colbers GJ; Menheere PP; Nieuwenhuijzen Kruseman AC Diabet Med; 1993 Jun; 10(5):427-30. PubMed ID: 8334821 [TBL] [Abstract][Full Text] [Related]
52. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control. De Pablos PL; Martinez J; Martinez MP; Doreste JA Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644 [TBL] [Abstract][Full Text] [Related]
53. Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy. Gruden G; Cavallo-Perin P; Olivetti C; Repetti E; Sivieri R; Bruno A; Pagano G Diabetologia; 1995 Oct; 38(10):1218-22. PubMed ID: 8690175 [TBL] [Abstract][Full Text] [Related]
54. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition? Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211 [TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Cusi K; Cunningham GR; Comstock JP Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511 [TBL] [Abstract][Full Text] [Related]
56. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Hiraga T; Kobayashi T; Okubo M; Nakanishi K; Sugimoto T; Ohashi Y; Murase T Diabetes Care; 1995 Feb; 18(2):241-4. PubMed ID: 7729305 [TBL] [Abstract][Full Text] [Related]
57. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Purnell JQ; Marcovina SM; Hokanson JE; Kennedy H; Cleary PA; Steffes MW; Brunzell JD Diabetes; 1995 Oct; 44(10):1218-26. PubMed ID: 7556961 [TBL] [Abstract][Full Text] [Related]
58. Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. Wägner AM; Pérez A; Sánchez-Quesada JL; Ordóñez-Llanos J Diabetes Care; 2005 Jul; 28(7):1798-800. PubMed ID: 15983340 [No Abstract] [Full Text] [Related]
59. The transport of vitamin E in plasma and its correlation to plasma lipoproteins in non-insulin-dependent diabetes mellitus. Kökoğlu E; Ulakoğlu E Diabetes Res Clin Pract; 1991 Dec; 14(3):175-81. PubMed ID: 1778110 [TBL] [Abstract][Full Text] [Related]
60. Comparison of a homogeneous assay with a precipitation method for the measurement of HDL cholesterol in diabetic patients. Jensen T; Truong Q; Frandsen M; Dinesen B; Stender S Diabetes Care; 2002 Nov; 25(11):1914-8. PubMed ID: 12401732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]